Skip navigation

BioWednesday Cambridge: From the Golden Gate to the Golden Triangle

17:30 - 20:30

Tamburlaine Hotel, 27-29 Station Road, Cambridge CB1 2FB
27 June 2018

Several reports including ‘From the Golden Gate to the Golden Triangle’ highlighted the increasing investments from the US, especially the west coast, in UK innovative companies. They represented 252% more deals in 2017 compared to 2011 cross tech sectors. This trend also applies to life sciences where we’ve seen a total value of deals of £472M in the same period, coming directly from west coast investors.

The increase of both number and volume of deals reflects an appetite not only for early stage technologies but also for scaling up support.  
Arguments in favour of UK life sciences often quoted are the excellence of science, talent pool and the lower valuations compared to American standards. 

This event will review these trends with data and real examples, and will explore on how to build on this dynamic to strengthen the life science sector on both sides of the Atlantic. 

17.30 – Registration and Networking over Coffee and Tea

18.00 – Welcome from the Hosts
Nick Richards, Penningtons Manches
Aline Charpentier, One Nucleus

18.10 – ‘From the Golden Gate to the Golden Triangle’ Findings
Henry Whorwood, Beauhurst 

18.30 – Building on US West Coast - Cambridge Success Stories
John Haurum, CEO, F-star Nigel Crockett, VP Business Development, Microbiotica
Anthony Finbow, CEO, Eagle Genomics

19.20 – Closing Remarks and Drinks Reception

20.30 – End 

Members: free 
Non-members: £50 (plus vat) 
Academics: please contact

Title: BioWednesday Cambridge: From the Golden Gate to the Golden Triangle
Start: 2018-06-27 17:30:00Z
End: 2018-06-27 20:30:00Z